| Jeffery Johnson Muir, MD | |
|
343 Elm St Ste 202, Reno, NV 89503-4538 | |
| (775) 870-1480 | |
| Not Available |
| Full Name | Jeffery Johnson Muir |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 16 Years |
| Location | 343 Elm St Ste 202, Reno, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255596722 | NPI | - | NPPES |
| P00970250 | Other | MN | RAILROAD MEDICARE |
| ENROLLED | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | 14611 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Renown Regional Medical Center | Reno, NV | Hospital |
| Renown South Meadows Medical Center | Reno, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jeffrey Zollinger D O Pc | 5597980326 | 9 |
News Archive
Politico reports that the expected ruling could be another blow for the White House. Meanwhile, The Hill analyzes the importance of the fact that all the judges who have ruled thus far on health law challenges have agreed that the individual mandate involves a penalty, not a tax.
A new study indicates that educational literature can influence young women's use of indoor tanning, not by raising their fear of skin cancer but by changing their attitudes about indoor tanning and promoting healthier alternatives for changing appearance.
A major breakthrough in lupus research - one that may fundamentally change thinking on how the disease affects behavior and cognition - was reported in the January 17, 2006 Proceedings of the National Academy of Sciences (PNAS).
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today an agreement to acquire a controlling stake of Shenzhen Shenke Medical Instrument Technical Development Co. Ltd. The terms of the transaction were not disclosed as the transaction is non-material to Mindray's financial statements.
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
› Verified 2 days ago
| Entity Name | Jeffrey Zollinger D O Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982018206 PECOS PAC ID: 5597980326 Enrollment ID: O20140710000894 |
News Archive
Politico reports that the expected ruling could be another blow for the White House. Meanwhile, The Hill analyzes the importance of the fact that all the judges who have ruled thus far on health law challenges have agreed that the individual mandate involves a penalty, not a tax.
A new study indicates that educational literature can influence young women's use of indoor tanning, not by raising their fear of skin cancer but by changing their attitudes about indoor tanning and promoting healthier alternatives for changing appearance.
A major breakthrough in lupus research - one that may fundamentally change thinking on how the disease affects behavior and cognition - was reported in the January 17, 2006 Proceedings of the National Academy of Sciences (PNAS).
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today an agreement to acquire a controlling stake of Shenzhen Shenke Medical Instrument Technical Development Co. Ltd. The terms of the transaction were not disclosed as the transaction is non-material to Mindray's financial statements.
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffery Johnson Muir, MD 343 Elm St Ste 202, Reno, NV 89503-4538 Ph: (775) 870-1480 | Jeffery Johnson Muir, MD 343 Elm St Ste 202, Reno, NV 89503-4538 Ph: (775) 870-1480 |
News Archive
Politico reports that the expected ruling could be another blow for the White House. Meanwhile, The Hill analyzes the importance of the fact that all the judges who have ruled thus far on health law challenges have agreed that the individual mandate involves a penalty, not a tax.
A new study indicates that educational literature can influence young women's use of indoor tanning, not by raising their fear of skin cancer but by changing their attitudes about indoor tanning and promoting healthier alternatives for changing appearance.
A major breakthrough in lupus research - one that may fundamentally change thinking on how the disease affects behavior and cognition - was reported in the January 17, 2006 Proceedings of the National Academy of Sciences (PNAS).
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today an agreement to acquire a controlling stake of Shenzhen Shenke Medical Instrument Technical Development Co. Ltd. The terms of the transaction were not disclosed as the transaction is non-material to Mindray's financial statements.
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
› Verified 2 days ago
Kristen Anne Smith, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1664 N Virginia St, Reno, NV 89557 Phone: 775-327-2182 | |
Mrs. Teresa May Morros, CBIS Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1325 Airmotive Way, #175r, Reno, NV 89502 Phone: 775-473-1077 | |
Nicholas Patrick Gut, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1495 Mill St, Reno, NV 89502 Phone: 775-982-5000 Fax: 775-982-8100 | |
Jesson Baumgartner, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 343 Elm St Ste 202, Reno, NV 89503 Phone: 775-870-1480 Fax: 877-764-6351 | |
Dr. Stephen Brown, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1540 Fescue Ct, Reno, NV 89509 Phone: 775-391-7780 | |
Mr. George Mars, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 645 Sierra Rose #202, Reno, NV 89511 Phone: 775-825-9990 Fax: 775-827-1161 | |
Dr. Edwin Gary Starr, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 403 Hill St Ste 2, Reno, NV 89501 Phone: 775-544-6401 |